Back
Protagonist Therapeutics, Inc. Vs. Johnson & Johnson Industry Stock Comparison
Sell
38
PTGX
Protagonist Therapeutics, Inc.
Last Price:
$87.86
Seasonality Move:
15.02%
Buy
54
JNJ
Johnson & Johnson
Last Price:
$207.58
Seasonality Move:
1.72%
Sell
38
Protagonist Therapeutics, Inc. (PTGX)
is a Sell
Is Protagonist Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Protagonist Therapeutics, Inc. [PTGX] share price is $87.93. The Score for PTGX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Johnson & Johnson (JNJ)
is a Buy
Is Johnson & Johnson a Buy, Sell or Hold?
-
The current Johnson & Johnson [JNJ] share price is $207.56. The Score for JNJ is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
JNJ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics, Inc.'s stock price today?
-
The Protagonist Therapeutics, Inc. share price today is $87.93Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight selling pressure.
JNJ Stock Price Chart
What is Johnson & Johnson's stock price today?
-
The Johnson & Johnson share price today is $207.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JNJ is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 24.46 | Buy |
| Relative Strength Index (14 RSI): | 51.22 | Buy |
| Chaikin Money Flow: | -111937 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (86.24 - 91.62) | Sell |
| Bollinger Bands (100): | (60.08 - 86) | Buy |
JNJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.29 | Buy |
| Relative Strength Index (14 RSI): | 56.45 | Buy |
| Chaikin Money Flow: | -3599769 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (203.51 - 209.75) | Buy |
| Bollinger Bands (100): | (177.62 - 201.76) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 87.86 | Buy |
| 20-day SMA: | 89.02 | Sell |
| 50-day SMA: | 84.23 | Buy |
| 200-day SMA: | 61.5 | Buy |
| 8-day EMA: | 76.29 | Buy |
| 20-day EMA: | 48.46 | Buy |
| 50-day EMA: | 24.07 | Buy |
| 200-day EMA: | 6.76 | Buy |
JNJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 207.64 | Sell |
| 20-day SMA: | 206.74 | Buy |
| 50-day SMA: | 199.36 | Buy |
| 200-day SMA: | 173.48 | Buy |
| 8-day EMA: | 207.57 | Sell |
| 20-day EMA: | 206.23 | Buy |
| 50-day EMA: | 200.04 | Buy |
| 200-day EMA: | 179.76 | Buy |
Protagonist Therapeutics, Inc. Earnings Growth & PTGX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.50 per share, and an increase next year of $2.93 per share.
Johnson & Johnson Earnings Growth & JNJ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $0.67 per share.
Protagonist Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Johnson & Johnson Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||